Northwest & Ethical Investments L.P. raised its holdings in Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 5.2% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 59,186 shares of the semiconductor company's stock after buying an additional 2,906 shares during the quarter. Northwest & Ethical Investments L.P.'s holdings in Synopsys were worth $25,381,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Cornerstone Planning Group LLC boosted its stake in shares of Synopsys by 275.0% in the 1st quarter. Cornerstone Planning Group LLC now owns 60 shares of the semiconductor company's stock valued at $25,000 after purchasing an additional 44 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd boosted its stake in shares of Synopsys by 441.7% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 65 shares of the semiconductor company's stock valued at $28,000 after purchasing an additional 53 shares in the last quarter. Ameriflex Group Inc. acquired a new stake in shares of Synopsys in the 4th quarter valued at $29,000. Cloud Capital Management LLC acquired a new stake in shares of Synopsys in the 1st quarter valued at $36,000. Finally, Meeder Asset Management Inc. boosted its stake in shares of Synopsys by 33.3% in the 1st quarter. Meeder Asset Management Inc. now owns 104 shares of the semiconductor company's stock valued at $45,000 after purchasing an additional 26 shares in the last quarter. Institutional investors own 85.47% of the company's stock.
Synopsys Trading Down 2.0%
NASDAQ:SNPS traded down $12.54 on Tuesday, hitting $612.79. 1,170,182 shares of the stock were exchanged, compared to its average volume of 1,430,034. The stock has a market capitalization of $95.08 billion, a price-to-earnings ratio of 44.24, a P/E/G ratio of 4.14 and a beta of 1.15. Synopsys, Inc. has a 52 week low of $365.74 and a 52 week high of $651.73. The company has a debt-to-equity ratio of 1.01, a quick ratio of 6.85 and a current ratio of 7.02. The company's 50-day moving average price is $563.66 and its 200 day moving average price is $499.14.
Synopsys (NASDAQ:SNPS - Get Free Report) last announced its quarterly earnings data on Wednesday, May 28th. The semiconductor company reported $3.67 earnings per share for the quarter, topping the consensus estimate of $3.40 by $0.27. The firm had revenue of $1.60 billion during the quarter, compared to analysts' expectations of $1.60 billion. Synopsys had a return on equity of 17.09% and a net margin of 34.77%.The company's quarterly revenue was up 10.3% compared to the same quarter last year. During the same period in the previous year, the business posted $3.00 EPS. Synopsys has set its FY 2025 guidance at 15.110-15.190 EPS. Q3 2025 guidance at 3.820-3.87 EPS. On average, equities research analysts forecast that Synopsys, Inc. will post 10.64 earnings per share for the current year.
Analyst Upgrades and Downgrades
Several brokerages have recently commented on SNPS. The Goldman Sachs Group began coverage on shares of Synopsys in a research note on Thursday, July 10th. They issued a "buy" rating and a $620.00 target price on the stock. Morgan Stanley restated an "overweight" rating and issued a $715.00 target price (up previously from $540.00) on shares of Synopsys in a research note on Monday, August 11th. KeyCorp boosted their target price on shares of Synopsys from $540.00 to $610.00 and gave the company an "overweight" rating in a research note on Thursday, July 10th. Bank of America upped their price target on shares of Synopsys from $575.00 to $625.00 and gave the stock a "buy" rating in a research report on Wednesday, July 16th. Finally, Needham & Company LLC reiterated a "buy" rating and set a $660.00 price target (up previously from $650.00) on shares of Synopsys in a research report on Tuesday, July 15th. Thirteen investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $630.67.
Read Our Latest Report on Synopsys
Insiders Place Their Bets
In other news, CFO Shelagh Glaser sold 7,310 shares of the company's stock in a transaction dated Friday, June 6th. The stock was sold at an average price of $485.72, for a total value of $3,550,613.20. Following the completion of the sale, the chief financial officer directly owned 15,291 shares of the company's stock, valued at $7,427,144.52. This represents a 32.34% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CRO Richard S. Mahoney sold 9,010 shares of the company's stock in a transaction dated Wednesday, June 18th. The shares were sold at an average price of $471.21, for a total value of $4,245,602.10. Following the completion of the sale, the executive directly owned 1,485 shares of the company's stock, valued at approximately $699,746.85. This trade represents a 85.85% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 27,686 shares of company stock valued at $13,001,048. 0.62% of the stock is currently owned by insiders.
Synopsys Company Profile
(
Free Report)
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
See Also

Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.